Gabelli reiterates ‘buy’ rating for LDR stock: 4 points

Gabelli analysts reiterated LDR stock’s “buy” rating, according to a Risers & Fallers report.

Advertisement

Here are four points:

 

1. Gabelli has given LDR stock a price target of $38.

 

2. The stock’s 50-day moving average is $24.96 and its 200-day moving average is $23.49.

 

3. LDR has a 52-week low of $16.33 and a 52-week high of $47.12.

 

4. The stock’s market capitalization is $806.81 million.

 

More articles on devices:
Lattice Biologics to launch three MAR products — 3 highlights
Bone Biologics completes $5M+ financing round: 3 things to know
RTI Surgical launches laminoplasty fixation system: 4 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.